Skip to Content
Uncategorized

A Little Insurance Problem for Nanotech

Several recent research studies have highlighted the uncertainties about the health and environmental risks associated with nanotechnology. Now the insurance industry is taking notice of those uncertainties: major Swiss reinsurer (insurance for the insurance companies) Swiss Re has issued a…

Several recent research studies have highlighted the uncertainties about the health and environmental risks associated with nanotechnology. Now the insurance industry is taking notice of those uncertainties: major Swiss reinsurer (insurance for the insurance companies) Swiss Re has issued a report suggesting that insurance companies may want to take a second look at covering products manufactured using nanotechnology until more is known about any possible side effects.

The recommendation is in line with Europe’s traditional “wait and see” approach regarding the adoption of potentially risky new technologies (genetically modified crops, anyone?) versus the headlong rush into new fields more typical in the U.S. As Swiss Re points out in an analysis on their website, “The insurance industry is concerned because scientific evaluations of potential risks for human health and the environment are few and remain inconclusive.”

The company isn’t looking to stymie progress in the field, though; the report goes on to say, “The only way to prevent a polarized debate about nanotechnology, which may slow down future research and economic growth in this field, is to find a common approach to lessen the uncertainty and to provide some answers for pressing questions concerning potential nanotoxicity and pollution issues.” Good advice for anyone in the field, scientist, businessperson, or insurer.

Deep Dive

Uncategorized

Embracing CX in the metaverse

More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.

Identity protection is key to metaverse innovation

As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.

The modern enterprise imaging and data value chain

For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.

Scientists have created synthetic mouse embryos with developed brains

The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.